Protein arginine deiminase 4 (PAD4) mediates the transformation of protein arginine into citrulline. Citrullination of proteins has normal roles in gene regulation and pathological roles in immunological and inflammatory diseases. GSK121 is the initial compound identified in a screen for PAD4 inhibitors and was optimized to produce the more potent PAD4 inhibitors, GSK484 and GSK199 . GSK121 was shown to inhibit the citrullination of PAD4 target proteins in a functional assay with an IC value of 3.2 µM.
GSK121 (trifluoroacetate salt) is a selective PAD4 inhibitor. GSK121 (trifluoroacetate salt) can be used in the research of PAD4-related diseases, including those characterized by abnormal NET levels and various tumors.
分子式
C25H26F3N5O3
分子量
501.50
CAS号
1652591-80-4
运输条件
Room temperature in continental US; may vary elsewhere.